PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Subdivisions of Program Areas, these track general higher level sub-classifications of expenditure.
Subdivisions of Major categories, these are the most detailed expenditure data.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
The emphasis area of this activity is to improve the diagnosis of TB among HIV-infected persons through
enhancement of tuberculosis laboratory capacity.
In FY 08, the USG will work alongside the Cambodia national TB program (CENAT) to expand capacity for
culture and drug-susceptibility testing at the one national laboratory and one provincial laboratory. The
target population includes all HIV-infected persons in HIV care services, as any of these persons would be
able to get sputum culture if needed. Making liquid culture available would be a major focus of this
laboratory expansion. Other laboratory enhancements would include strengthening external quality
assurance and proficiency testing in those laboratories for microscopy and solid culture, training, and
development of human resources. This activity augments current GFATM activities, which support smear
microscopy and chest radiography, both of which are components of TB diagnosis in HIV-infected persons.
In addition to enhancing laboratory capacity, the USG will also develop a transportation network to deliver
specimens from HIV care facilities in Pursat, Battambang, and Banteay Meanchey to the provincial
laboratory, which is in Battambang, one of 3 provinces in which the USG supports TB/HIV activities.
Banteay Meanchey and Pursat, the other two provinces the USG supports are adjacent to Battambang.
This activity links to other TB/HIV activities by improving the diagnosis of TB among HIV-infected persons in
HIV care within these 3 provinces, which increases the number of HIV-infected persons diagnosed with TB
and excludes TB for a larger group of HIV-infected persons, thus allowing the initiation of isoniazid
preventive therapy in these provinces.
In FY 08, the USG will continue to engage partners, including the Tuberculosis Control Assistance Program
(TBCAP) and the Japan Anti-Tuberculosis Association (JATA) to assist with the development of this system.
In order to achieve the above results, the USG will conduct: site-assessments of existing TB laboratories in
Battambang and at CENAT, fund any renovations needed prior to implementing liquid culture, procure
supplies and equipment needed, provide training for solid and liquid-based culture techniques, identification,
and drug-susceptibility testing, develop systems for transport of specimens to the laboratories, strengthen
laboratory information management system for monitoring and evaluation of laboratory capacity
enhancements, provide technical assistance for all aspects of this work.